Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE Other stock markets 06:00:02 08/08/26 am AEST			5-day change	1st Jan Change
352.47 ^USD	+2.93%		+8.29%	+16.33%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	9.35B	BBB
ABBOTT LABORATORIES	187B	BBB
MEDTRONIC PLC	112B	BBB
CENCORA, INC.	61.15B	AA
HOYA CORPORATION	54.39B	AAA
BECTON, DICKINSON AND COMPANY	48.17B	A
DEXCOM, INC.	31.98B	BBB
MEDLINE INC.	30.91B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.92B	AA
STERIS PLC	23.14B	AAA	-
TERUMO CORPORATION	22.2B	AA
SARTORIUS STEDIM BIOTECH	20.01B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.42B	A
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	14.42B	A
SOLVENTUM CORPORATION	14.13B	BBB
BAXTER INTERNATIONAL INC.	14.24B	A
ALIGN TECHNOLOGY, INC.	12.34B	A
GLOBUS MEDICAL, INC.	11.06B	CCC
INSULET CORPORATION	9.79B	A
DEMANT A/S	9.2B	AA
Average	36.4B	A
Weighted average by Cap.		A